WallStSmart
DFTX

Definium Therapeutics, Inc.

NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY

$21.40
-2.95% today

Updated 2026-05-11

Market cap
$2.40B
P/E ratio
P/S ratio
EPS (TTM)
$-2.50
Dividend yield
52W range
$6 – $26
Volume
1.9M

Definium Therapeutics, Inc. (DFTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-34.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-102.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-5.8%
2026-05-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-05-07$-0.71-48.9%$23.42$22.05-5.8%
2026-03-05$-0.50+1.1%$17.76$17.66-0.6%
2025-11-06$-0.78-56.0%$11.53$11.70+1.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.48$-0.71-48.9%
2025-12-31$-0.51$-0.50+1.1%
2025-09-30$-0.50$-0.78-56.0%
2025-06-30$-0.37$-0.50-35.1%
2025-03-31$-0.34$-0.35-2.9%
2024-12-31$-0.31$-0.41-32.3%
2024-09-30$-0.28$-0.18+35.7%
2024-06-30$-0.33$-0.26+21.2%
2024-03-31$-0.42$-1.14-171.4%
2023-12-31$-0.46$-2.44-427.1%
2023-09-30$-0.65$-0.45+30.8%
2023-06-30$-0.53$-0.76-43.4%

Frequently asked questions

Has Definium Therapeutics, Inc. beaten earnings estimates?
Definium Therapeutics, Inc. has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -34.7% over the last 4 quarters.
How does DFTX stock react to earnings?
DFTX stock has moved an average of -1.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.